We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

The first time Johnson & Johnson faced a lawsuit due to its talc-based baby powder causing cancer was way back in 1999. Since ...

Johnson & Johnson (JNJ), with a market cap of $377.3 billion, is a leading healthcare company based in New Brunswick, New ...

As of November 07, 2024, Johnson & Johnson had a $380.1 billion market capitalization, putting it in the 100th percentile of companies in the Pharmaceuticals industry. Currently, Johnson & Johnson’s ...

ONL Therapeutics Inc. is a classic case of a University of Michigan spinout. The Ann Arbor biotechnology startup netted the largest VC deal in the state in Q3, closing an oversubscribed $65 million ...

it wasn't until 1959 – 73 years and two major acquisitions later – that J&J developed its significant presence in the pharmaceutical industry. In 1886, three brothers – Robert Wood Johnson ...

Experts in the neuropsychiatry drug development space say targeting the right patient population will be key for success in ...

The EMA has accepted a MAA for Alvotech and Advanz Pharma’s AVT05, a proposed biosimilar to Johnson & Johnson’s (J&J) Simponi ...

His name is familiar to every student who enters the Behrakis Health Science Center, which for two decades has served as a ...

With the rise in global counterfeiting operations, stakeholders need to be aware of their responsibility when it comes to pharmaceutical goods and their legitimacy. Companies can make this task easier ...

Proceeds expected to support the upcoming planned launches and fund the continued development of Niktimvo and revumenibExpected to fund Syndax through profitability; proforma cash approaching $800 mil ...